A Year in Patents - 2019 Issue 3 March 2020 6681 Editor's Note Welcome to our annual review of patent law and practice developments. Read more 6698 FRAND Cases concerning standard essential patents (SEPs) and FRAND (fair, reasonable and non-discriminatory) licensing, and the UK courts’ approach to these disputes, continue to dominate the headlines. Read more 6696 Infringement and validity The Supreme Court’s 2017 decision in Actavis v Eli Lilly introduced a doctrine of equivalents (DOE) into UK law. In the two years that have followed, the new approach to claim construction has been a matter of considerable debate (see in particular, the Court of Appeal’s decision in Icescape v Ice-World discussed in our 2018 Review). Read more 6702 Remedies The Patents Court rejected an application for an interim injunction in Abbott v Edwards. Whilst the facts of the caseare perhaps unusual, the decision is a reminder that, wherea patent owner cannot establish that it will suffer irreparableand unquantifiable harm, it will not be possible to obtain an interim injunction. Read more 6704 SPCs SPCs continue to be a focus of regulatory and judicial development, though the CJEU refused to consider a reference from the UK court in Eli Lilly v Genentech on the question of whether an SPC should be granted to a patent owner that relies upon a third party’s marketing authorisation. Read more Previous Issues Prev Next Issue 4 Mar 2021 Issue 3 Mar 2020 Issue 2 Mar 2019 Issue 1 Jan 2018 Services Intellectual Property Intellectual Property Disputes Life Sciences Patents Technology People David Rose Share